Overview
Baojian Wu practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Colitis, Delirium, Viral Gastroenteritis, and Malabsorption.
They are actively involved in clinical research, co-authoring 168 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Baojian L. Wu
Is Baojian L. Wu a top-rated expert for Colitis?
MediFind is an objective health platform that identifies experts based on real-world data. Baojian L. Wu is classified as an Experienced expert for Colitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Baojian L. Wu participate in research or clinical trials?
Yes. Baojian L. Wu has published 168 articles and abstracts on conditions like Colitis. You can view a list of Baojian L. Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Absence SeizureWu isExperienced. Learn about Absence Seizure.
- Breast CancerWu isExperienced. Learn about Breast Cancer.
- ColitisWu isExperienced. Learn about Colitis.
- DeliriumWu isExperienced. Learn about Delirium.
- Generalized Tonic-Clonic Seizure
- MalabsorptionWu isExperienced. Learn about Malabsorption.